build the standalone rcp debugger against the latest simrel mvn verify -DuseSimrelRepo -f debug/.application.product.test CDT against a pre-built CDT by using the cdtRepo profile.Individual p2 repos can be turned on and off to allow building CDT, or parts of CDT against different target platforms easily. There are a number of profiles (-P to mvn) to control the behaviour of the build. Refer to the Dockerfiles for the current versions of those dependencies. The requirements for running all tests successfully and for rebuilding non-Java parts of CDT are much more extensive than standard Maven & Java and include items such as GCC, GDB, yarn, Node, etc. The Dockerfiles used for CDT's images are published in cdt-infra. To build CDT plug-ins you need a standard Maven & Java developement environment. The current set of options to Maven used for building on the CI can be seen in the Jenkinsfiles on cdt-infra Therefore to package CDT do: mvn packageĪnd the resulting p2 repository will be in releng//target/repository Command-line Build instructions with MavenĮclipse CDT uses the standard Maven and Tycho workflow for building CDT using Maven 3.6.0 and Java 8. Most developers, developing CDT in the Eclipse IDE, should use Getting_started_with_CDT_development. Please see CONTRIBUTING.md for contributing information Developing CDT terminal/features/.terminal.feature/feature.xml.
releng/.branding/META-INF/MANIFEST.MF.memory/.ui.memory-feature/feature.xml.This will result in the CDT help files being available, but the C/C++ perspective and C/C++ project type being unavailable, due to probably a package collision (although strangely, nothing was showing up in my workspace. jtag/.dap.gdbjtag-feature/feature.xml Do not select both C/C++ Development Tools and C/C++ Development Tools SDK.dsf-gdb/.multicorevisualizer-feature/feature.xml.debug/.standalone-feature/feature.xml.debug/.application/META-INF/MANIFEST.MF.core/.linux.x86_64/META-INF/MANIFEST.MF.core/.linux.ppc64le/META-INF/MANIFEST.MF.core/.linux.aarch64/META-INF/MANIFEST.MF.
0 kommentar(er)
